378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies

Vincent de Weger, Martijn P. Lolkema, Mark A. Dickson, Axel Le Cesne, Andrew J. Wagner, M. Merqui-Roelvink, Andréa Varga, W. Tap, Gerri E. Schwartz, George D. Demetri,

European Journal of Cancer · 2014 · 10 citations · 0 references

Concepts